David Calvet Canut on Europe’s Plasma Dependency
David Calvet Canut, Director TFE at UNIR, shared on LinkedIn:
”Europe’s reliance on imported plasma is a critical issue that demands immediate attention.
The use of plasma in producing vital medical components underscores its importance in healthcare.
However, Europe’s heavy dependence on U.S. imports jeopardizes patient care and the stability of the medical supply chain.
This situation also raises ethical concerns, as purely profit-driven approaches may compromise patient safety and well-being.
Addressing this challenge requires a comprehensive strategy that integrates legal, ethical, and scientific considerations.
By enhancing local plasma sourcing and adopting robust governance measures, Europe can strengthen its healthcare resilience and ensure a sustainable supply of essential therapeutics.
Emphasizing donor safety, ethical standards in medicine, and strong governance practices is paramount to safeguarding the region’s health infrastructure.
Misaligned countries’ policies and standards could represent a risk for companies crossing the red lines of legal and ethic frameworks even without being fully aware of such behavior.”
Read the full article here.
Stay updated with Hemostasis Today.
-
Sep 4, 2026, 18:49Børge Nordestgaard: Lp(a) Remains a Risk Factor Across the Lifespan
-
Sep 4, 2026, 18:22Tareq Abadl: The Clinical Meaning of C3 and C4
-
Sep 4, 2026, 18:16How Mutant p53 Hijacks VWF Expression in Tumor Cells – JTH
-
Sep 4, 2026, 18:08Simon Kraler: Can the Adrenomedullin System Predict Cardiogenic Shock Before It Happens?
-
Sep 4, 2026, 17:56Maxime Dely: Why Every Blood Donation Matters
-
Sep 4, 2026, 17:28Shinya Goto: When Cardiovascular Risk Gets Lower, RCTs Get Harder
-
Sep 4, 2026, 16:55New Orleans Is Calling ASH26 Is Near
-
Sep 4, 2026, 16:48ESC Congress 2026 – My Top 20 Lipidology Highlights Shaping the Future of Cardiovascular Prevention – Pablo Corral
-
Sep 4, 2026, 16:38Felice Gragnano։ Turning Cardiovascular Risk Into Action